Early development of histiocytic sarcomas in p53 knockout mice treated with N-bis(2-hydroxypropyl)nitrosamine

  • Authors:
    • Akihiro Hirata
    • Tetsuya Tsukamoto
    • Masami Yamamoto
    • Shinji Takasu
    • Hiroki Sakai
    • Hisayo Ban
    • Tokuma Yanai
    • Toshiaki Masegi
    • Lawrence A. Donehower
    • Masae Tatematsu
  • View Affiliations

  • Published online on: October 1, 2007     https://doi.org/10.3892/or.18.4.755
  • Pages: 755-761
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

p53 knockout mice have been utilized for the functional analysis of p53 in carcinogenic processes and for the evaluation of the carcinogenic potential of chemicals. In this study, we established that p53 knockout mice have an elevated susceptibility to the induction of histiocytic sarcoma (HS) by N-bis(2-hydroxy-propyl)nitrosamine (BHP). p53 heterozygous (+/−) and wild-type (+/+) mice were treated with 20 or 200 ppm BHP in their drinking water for 15 weeks or with 20 ppm BHP for 40 weeks. An additional group of p53 nullizygous (−/−) mice were treated with 20 ppm BHP for 15 weeks. In a 15-week experiment, hepatic HSs were unexpectedly observed in BHP-treated p53 (−/−) mice (30.8%) but not in p53 (+/−) and (+/+) mice and untreated (−/−) mice, indicating that a complete loss of p53 dramatically accelerates the genesis of HS. In a 40-week experiment, HSs were significantly increased in female p53 (+/−) mice (37.5%) as compared with female (+/+) mice (5.0%). Additionally, PCR-SSCP and sequencing analysis revealed a high frequency of p53 gene mutations in HSs, demonstrating the involvement of p53 gene mutations in HS development. Our data add to the understanding of the carcinogenic susceptibility of p53 knockout mice, and may help to elucidate the pathogenesis of HS development.

Related Articles

Journal Cover

October 2007
Volume 18 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hirata A, Tsukamoto T, Yamamoto M, Takasu S, Sakai H, Ban H, Yanai T, Masegi T, Donehower LA, Tatematsu M, Tatematsu M, et al: Early development of histiocytic sarcomas in p53 knockout mice treated with N-bis(2-hydroxypropyl)nitrosamine. Oncol Rep 18: 755-761, 2007
APA
Hirata, A., Tsukamoto, T., Yamamoto, M., Takasu, S., Sakai, H., Ban, H. ... Tatematsu, M. (2007). Early development of histiocytic sarcomas in p53 knockout mice treated with N-bis(2-hydroxypropyl)nitrosamine. Oncology Reports, 18, 755-761. https://doi.org/10.3892/or.18.4.755
MLA
Hirata, A., Tsukamoto, T., Yamamoto, M., Takasu, S., Sakai, H., Ban, H., Yanai, T., Masegi, T., Donehower, L. A., Tatematsu, M."Early development of histiocytic sarcomas in p53 knockout mice treated with N-bis(2-hydroxypropyl)nitrosamine". Oncology Reports 18.4 (2007): 755-761.
Chicago
Hirata, A., Tsukamoto, T., Yamamoto, M., Takasu, S., Sakai, H., Ban, H., Yanai, T., Masegi, T., Donehower, L. A., Tatematsu, M."Early development of histiocytic sarcomas in p53 knockout mice treated with N-bis(2-hydroxypropyl)nitrosamine". Oncology Reports 18, no. 4 (2007): 755-761. https://doi.org/10.3892/or.18.4.755